Stimulation of Matrix Metalloproteinase-9 Expression in Human Fibrosarcoma Cells by Synthetic Matrix Metalloproteinase Inhibitors
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 275 (1) , 110-121
- https://doi.org/10.1006/excr.2002.5489
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell developmentJournal of Cellular Physiology, 2001
- Molecular regulation of cellular invasion— role of gelatinase A and TIMP-2Biochemistry and Cell Biology, 1996
- Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancerEuropean Journal Of Cancer, 1996
- Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cellsJournal of Cellular Physiology, 1996
- Markedly Elevated Serum MMP-9 (Gelatinase B) Levels in Rheumatoid Arthritis: A Potentially Useful Laboratory MarkerClinical Immunology and Immunopathology, 1996
- Association Between Expression of Activated 72-Kilodalton Gelatinase and Tumor Spread in Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1993
- Constitutive Synthesis of a 92-kDa Keratinocyte-Derived Type IV Collagenase Is Enhanced by Type I Collagen and Decreased by Type IV Collagen MatricesJournal of Investigative Dermatology, 1992
- Induction and stimulation of 92-kDa gelatinase / type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor αBiochemical and Biophysical Research Communications, 1990
- Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.The Journal of cell biology, 1989
- Antisense RNA-Induced Reduction in Murine TIMP Levels Confers Oncogenicity on Swiss 3T3 CellsScience, 1989